| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 127779-20-8 | 沙奎那韋; 沙喹那韋; N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[(叔丁基氨基)甲酰]八氫-2(1H)-異喹啉基]-2-羥基-1-芐基 | Saquinavir; N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-butanediamide |  | C38H50N6O5 | 詳情 | 供應(yīng)商 |
| 257933-82-7 | 培利替尼; 貝利替尼; (2E)-N-[4-[(3-氯-4-氟苯基)氨基]-3-氰基-7-乙氧基-6-喹啉基]-4-(二甲基氨基)-2-丁烯酰? | Pelitinib; (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide |  | C24H23ClFN5O2 | 詳情 | 供應(yīng)商 |
| 55375-96-7 | 1-[(苯甲酰氨基)甲基]-1,2,3,4-四氫異喹啉; N-((1,2,3,4-四氫-1-異喹啉基)甲基)苯甲酰胺 | 1-(Benzamidomethyl)-1,2,3,4-tetrahydro-isoquinoline; N-((1,2,3,4-Tetrahydro-1-isoquinolinyl)methyl)benzamide |  | C17H18N2O | 詳情 | 供應(yīng)商 |
| 71832-69-4 | 2-[2-(2,3-二氫基-1,3-二氧基-1H-茚-2-基)-6-喹啉基]-6-甲基-7-苯并噻唑磺酸與2,2',2"-次氨基三乙醇的 | 7-Benzothiazolesulfonic acid, 2-[2-(2,3-dihydro-1,3-dioxo-1H-inden-2-yl)-6-quinolinyl]-6-methyl-, co; -nitrilotris[ethanol] (1：1) (9CI); olinyl]-6-methyl-, compd. with 2,2',2''-nitrilotris[ethanol] (1：1) | 無(wú) | C26H16N2O5S2.C6H15NO3 | 詳情 | 供應(yīng)商 |
| 123761-12-6 | 3-(2-喹啉基)-DL-丙氨酸; 2-氨基-3-(喹啉-2-基)丙酸 | 2-Quinolinepropanoicacid, a-amino-; 2-Quinolinepropanoicacid, a-amino-, (?à)-; 2-Quinolinealanine |  | C12H12N2O2 | 詳情 | 供應(yīng)商 |
| 74874-10-5 | (2R,4R)-1-[(2S)-5-[[亞硝胺甲基]氨基]-2-[[(3-甲基-8-喹啉基)�；腔鵠氨基]-1-氧代戊基]-4-甲基-2-哌啶甲酸 | 2-PIPERIDINECARBOXYLIC ACID, 1-[5-[IMINO(NITROAMINO)METHYL]AMINO]-2-[[(3-METHYL-8-QUINOLINYL)SULFONY; 2-PIPERIDINECARBOXYLIC ACID, 1-[5-[IMINO(NITROAMINO)METHYL]AMINO]-2-[[(3-METHYL-8-QUINOLINYL)SULFONYL]AMINO]-1-OXOPENTYL]-4-METHYL-,[2R-[1(S*), 2ALPHA, 4BETA]]-; 2-PIPERIDINECARBOXYLIC ACID, 1-[5-[[IMINO(NITROAMINO)METHYL]AMINO]-2-[[(3-METHYL-8-QUINOLINYL)SUFONYL]-1-OXOPENTYL]-4-METHYL-,[2R-[1(S*), 2ALPHA, 4BETA]]-; (2R,4R)-1-[Nitroglycerine-nitro-N2-(3-methyl-8-quinolinesulfonyl)-L-arginyl]-4-methyl-2-piperidinecarboxylic acid; [2R-[1(S*),2α,4β]]-1-[5-[[imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-; (2R,4R)-1-[(2S)-5-[[imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-Piperidinecarboxylic acid; [2R-[1(S*),2α,4β]]-1-[5-[[imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic acid |  | C23H31N7O7S | 詳情 | 供應(yīng)商 |
| 630420-16-5 | (1R,2S)-N-[(1,1-二甲基乙氧基)羰基]-3-甲基-L-纈氨酰-(4R)-4-[(7-氯-4-甲氧基-1-異喹啉基)氧基]-L-脯氨酰-1-氨基-N-(環(huán)丙基磺�；�)-2-乙烯基環(huán)丙基甲酰胺; (1R,2S)-N-[(1,1-二甲基乙氧基)羰基]-3-甲基-L-纈氨酰-(4R)-4-[(7-氯-4-甲氧基-1-異喹啉基)氧基]-L-脯氨酰-1-氨基-N-(環(huán)丙基磺�；�)-2-乙烯基環(huán)丙基甲酰胺; 阿那匹韋 | (1R,2S)-N-[(1,1-Dimethylethoxy)carbonyl]-3-methyl-L-valyl-(4R)-4-[(7-chloro-4-methoxy-1-isoquinolinyl)oxy]-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenylcyclopropanecarboxamide; (1R,2S)-N-[(1,1-Dimethylethoxy)carbonyl]-3-methyl-L-valyl-(4R)-4-[(7-chloro-4-methoxy-1-isoquinolinyl)oxy]-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenylcyclopropanecarboxamide; Asunaprevir; BMS 650032; Asunaprevir (BMS-650032); BMS 650032/Asunaprevir |  | C35H46ClN5O9S | 詳情 | 供應(yīng)商 |
| 1058137-23-7 | E 3810; 6-[[7-[(1-氨基環(huán)丙基)甲氧基]-6-甲氧基-4-喹啉基]氧基]-N-甲基-1-萘甲酰胺 | E-3810; E-3810; 6-[[7-[(1-Aminocyclopropyl)methoxy]-6-methoxy-4-quinolinyl]oxy]-N-methyl-1-naphthalenecarboxamide | 無(wú) | C26H25N3O4 | 詳情 | 供應(yīng)商 |
| 3820-67-5 | 格拉非寧; 格拉非寧; 2-[(7-氯-4-喹啉基)氨基]苯甲酸 2,3-二羥基丙酯 | 1-GLYCERYL N-[7-CHLORO-4-QUINOLYL]ANTHRANILATE HYDROCHLORIDE; GLAFENINE HYDROCHLORIDE; 1-GLYCERYL N-[7-CHLORO-4-QUINOLYL]ANTHRANILATE HYDROCHLORIDE; 4-((2-carboxyphenyl)amino)-7-chloroquinolinealpha-monoglyceride; 4-(2’-(beta,gamma-dihydroxypropoxycarbonyl)phenylamino)-7-chloroquinoleine; 4-(2’-beta,gamma-dihydroxypropoxycarbonylphenylamino)-7-chloroquinoline; adalgur; alicidon; anthranilicacid,n-(7-chloro-4-quinolyl)-,2,3-dihydroxypropylester |  | C19H17ClN2O4 | 詳情 | 供應(yīng)商 |